Chemours Balance Sheet Health

Financial Health criteria checks 1/6

Chemours has a total shareholder equity of $659.0M and total debt of $4.0B, which brings its debt-to-equity ratio to 605.8%. Its total assets and total liabilities are $7.5B and $6.8B respectively. Chemours's EBIT is $489.0M making its interest coverage ratio 1.9. It has cash and short-term investments of $596.0M.

Key information

605.8%

Debt to equity ratio

US$3.99b

Debt

Interest coverage ratio1.9x
CashUS$596.00m
EquityUS$659.00m
Total liabilitiesUS$6.80b
Total assetsUS$7.46b

Recent financial health updates

Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Jul 18
Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Recent updates

Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye

Nov 12
Chemours' (NYSE:CC) Earnings Offer More Than Meets The Eye

Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?

Sep 25
Is It Too Late To Consider Buying The Chemours Company (NYSE:CC)?

Chemours: We're Back Down To Trough And A 'BUY'

Sep 01

Chemours: Upside After Irregularities, Good 2024-2026E

Jun 11

The Chemours Company's (NYSE:CC) Low P/S No Reason For Excitement

May 30
The Chemours Company's (NYSE:CC) Low P/S No Reason For Excitement

Drama At The Chemours Company Opens The Door For Upside

Mar 29

The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%

Mar 01
The Chemours Company (NYSE:CC) Not Doing Enough For Some Investors As Its Shares Slump 37%

Chemours: The Case Amidst Board Trouble, I Say Buy The Weakness

Feb 29

Chemours (NYSE:CC) Has Announced A Dividend Of $0.25

Feb 17
Chemours (NYSE:CC) Has Announced A Dividend Of $0.25

Chemours: Technological Innovation Presents Excellent Opportunities For Growth

Dec 23

Chemours (NYSE:CC) Will Pay A Dividend Of $0.25

Oct 30
Chemours (NYSE:CC) Will Pay A Dividend Of $0.25

The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate

Oct 28
The Chemours Company (NYSE:CC) Shares Could Be 21% Above Their Intrinsic Value Estimate

Chemours: Volatile Bottom Line Needs Consistency

Oct 06

The Chemours Company: Portfolio Optimization Resulting In Compounding Growth

Sep 19

Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Jul 18
Chemours (NYSE:CC) Takes On Some Risk With Its Use Of Debt

Is There An Opportunity With The Chemours Company's (NYSE:CC) 48% Undervaluation?

Jul 03
Is There An Opportunity With The Chemours Company's (NYSE:CC) 48% Undervaluation?

The Chemours Company: On A Nice Run

Jul 03

Financial Position Analysis

Short Term Liabilities: CC's short term assets ($3.1B) exceed its short term liabilities ($1.8B).

Long Term Liabilities: CC's short term assets ($3.1B) do not cover its long term liabilities ($5.0B).


Debt to Equity History and Analysis

Debt Level: CC's net debt to equity ratio (515.3%) is considered high.

Reducing Debt: CC's debt to equity ratio has increased from 486% to 605.8% over the past 5 years.

Debt Coverage: CC's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: CC's interest payments on its debt are not well covered by EBIT (1.9x coverage).


Balance Sheet


Discover healthy companies